2666-7762

The Lancet Regional Health - Europe

Elsevier

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 1669 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact1669 DOIs
2

Attach ORCID iDs across 267 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact267 DOIs
3

Deposit reference lists for 117 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact117 DOIs

DOIs for this ISSN

Showing the top 5 of 1669 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Dynamics of antibody response to BNT162b2 vaccine after six… (10.1016/j.lanepe.2021.100208)
Abstract ORCID
132.52 446
2 The burden of mental disorders, substance use disorders and… (10.1016/j.lanepe.2022.100341)
Abstract ORCID
119.81 248
3 The Italian health data system is broken (10.1016/j.lanepe.2024.101206)
Abstract References ORCID
119.33 38
4 Securing the future of Europe's ageing population by 2050 (10.1016/j.lanepe.2023.100807)
Abstract References ORCID
112.89 31
5 Polycystic ovary syndrome: What more can be done for patient… (10.1016/j.lanepe.2022.100524)
Abstract References ORCID
111.85 30
6 Embracing generative AI in health care (10.1016/j.lanepe.2023.100677)
Abstract References ORCID
109.68 28
7 The regional and global impact of the Russian invasion of Uk… (10.1016/j.lanepe.2022.100379)
Abstract References ORCID
106.12 25
8 Sweden's economic inequality gap is widening and worrying (10.1016/j.lanepe.2023.100610)
Abstract References ORCID
104.85 24
9 Impact of SARS-CoV-2 Delta variant on incubation, transmissi… (10.1016/j.lanepe.2021.100278)
Abstract ORCID
102.07 109
10 Robotic versus open partial pancreatoduodenectomy (EUROPA):… (10.1016/j.lanepe.2024.100864)
Abstract ORCID
102.07 109
11 Long-term real-world effectiveness of allergy immunotherapy… (10.1016/j.lanepe.2021.100275)
Abstract ORCID
101.87 108
12 Severe COVID-19 in people with type 1 and type 2 diabetes in… (10.1016/j.lanepe.2021.100105)
Abstract ORCID
97.71 89
13 Prognostic utility of Fibrosis-4 Index for risk of subsequen… (10.1016/j.lanepe.2023.100780)
Abstract ORCID
97.71 89
14 Noise pollution: more attention is needed (10.1016/j.lanepe.2022.100577)
Abstract References ORCID
97.58 19
15 Semaglutide and beyond: a turning point in obesity pharmacot… (10.1016/j.lanepe.2024.100860)
Abstract References ORCID
94.15 17
16 Impact of poverty and family adversity on adolescent health:… (10.1016/j.lanepe.2021.100279)
Abstract ORCID
92.87 71
17 Population level physical activity before and during the fir… (10.1016/j.lanepe.2021.100265)
Abstract ORCID
88.91 59
18 Protecting infants against RSV disease: an impact and cost-e… (10.1016/j.lanepe.2023.100829)
Abstract ORCID
88.91 59
19 Time to integrate spiritual needs in health care (10.1016/j.lanepe.2023.100648)
Abstract References ORCID
88.21 14
20 Monkeypox, stigma and public health (10.1016/j.lanepe.2022.100536)
Abstract ORCID
88.17 57
21 Atrial fibrillation: pathophysiology, genetic and epigenetic… (10.1016/j.lanepe.2023.100785)
Abstract ORCID
86.21 52
22 Differences in incidence, nature of symptoms, and duration o… (10.1016/j.lanepe.2023.100630)
Abstract ORCID
85.80 51
23 A randomized, double-blind, placebo-controlled phase 1 trial… (10.1016/j.lanepe.2021.100084)
Abstract ORCID
85.38 50
24 Challenges of data sharing in European Covid-19 projects: A… (10.1016/j.lanepe.2022.100467)
Abstract ORCID
84.95 49
25 Strengthening primary health care to achieve universal healt… (10.1016/j.lanepe.2024.100897)
Abstract References ORCID
83.55 12
26 Lung cancer trends and tumor characteristic changes over 20… (10.1016/j.lanepe.2022.100492)
Abstract ORCID
82.66 44
27 PFMG2025–integrating genomic medicine into the national heal… (10.1016/j.lanepe.2024.101183)
Abstract ORCID
81.67 42
28 Challenges for addressing dementia (10.1016/j.lanepe.2022.100504)
Abstract References ORCID
78.10 10
29 Navigating disparities in cardiovascular disease outcomes ac… (10.1016/j.lanepe.2023.100746)
Abstract References ORCID
78.10 10
30 Corrigendum to “Consensus recommendation for prenatal, neona… (10.1016/j.lanepe.2024.100974)
Abstract References ORCID
78.10 10
31 Do asymptomatic carriers of SARS-COV-2 transmit the virus? (10.1016/j.lanepe.2021.100082)
Abstract ORCID
77.82 35
32 Changes in COVID-19 in-hospital mortality in hospitalised ad… (10.1016/j.lanepe.2021.100104)
Abstract ORCID
77.20 34
33 Lessons from COVID-19 are shaping the response to monkeypox… (10.1016/j.lanepe.2022.100463)
Abstract References ORCID
75.00 9
34 Psychedelic-assisted psychotherapy: hope and dilemma (10.1016/j.lanepe.2023.100727)
Abstract References ORCID
75.00 9
35 Nitrate in drinking water and risk of birth defects: Finding… (10.1016/j.lanepe.2021.100286)
Abstract ORCID
74.57 30
36 COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COV… (10.1016/j.lanepe.2022.100410)
Abstract ORCID
74.57 30
37 Association of stress-related disorders with subsequent risk… (10.1016/j.lanepe.2022.100402)
Abstract ORCID
73.86 29
38 Infection and transmission of SARS-CoV-2 in London care home… (10.1016/j.lanepe.2021.100038)
Abstract ORCID
73.12 28
39 Roll-out of HIV pre-exposure prophylaxis use in France: A na… (10.1016/j.lanepe.2022.100486)
Abstract ORCID
72.36 27
40 Seroprevalence of Measles-, Mumps-, and Rubella-specific ant… (10.1016/j.lanepe.2021.100128)
Abstract ORCID
71.57 26
41 Management of gout following 2016/2017 European (EULAR) and… (10.1016/j.lanepe.2022.100416)
Abstract ORCID
71.57 26
42 Misdiagnosis of type 1 and type 2 diabetes in adults (10.1016/j.lanepe.2023.100661)
Abstract References ORCID
71.57 8
43 Attitudes towards vaccines and intention to vaccinate agains… (10.1016/j.lanepe.2020.100012)
Abstract
71.34 713
44 Climate change and mental health: direct, indirect, and inte… (10.1016/j.lanepe.2024.100969)
Abstract ORCID
70.75 25
45 Prevalence of chronic HCV infection in EU/EEA countries in 2… (10.1016/j.lanepe.2023.100792)
Abstract ORCID
69.90 24
46 Post-COVID syndrome in non-hospitalised patients with COVID-… (10.1016/j.lanepe.2021.100122)
Abstract
68.69 558
47 Protecting the mental health of youth (10.1016/j.lanepe.2021.100306)
Abstract References ORCID
67.73 7
48 Long COVID: An opportunity to focus on post-acute infection… (10.1016/j.lanepe.2022.100540)
Abstract References ORCID
67.73 7
49 The cost-of-living crisis is also a health crisis (10.1016/j.lanepe.2023.100632)
Abstract References ORCID
67.73 7
50 Support not stigma: redefining perinatal mental health care (10.1016/j.lanepe.2024.100930)
Abstract References ORCID
67.73 7